Continuous and Intermittent Glucose Monitoring in 2023

Klemen Dovc,Bruce W Bode,Tadej Battelino,Bruce W. Bode
DOI: https://doi.org/10.1089/dia.2024.2502
2024-03-06
Diabetes Technology & Therapeutics
Abstract:In the last few years, continuous glucose monitoring (CGM) has established its pivotal role in individuals with diabetes treated with insulin. Recently, studies have evaluated a broadening role of CGM beyond insulin dosing titration guidance: CGM has been considered as a diagnostic tool for staging of (pre)type 1 diabetes (T1D), for therapy modification guidance for non-insulin-treated individuals with type 2 diabetes (T2D), or as an outcome measure for clinical trials.
endocrinology & metabolism
What problem does this paper attempt to address?